For instance, anti-CTLA-4 mAbs encapsulated inside the PEGylated liposomes, showed superior capacity for tumor reduction, and favorably changed the CD8+ effector T cell to Treg ratios in mice bearing C26 colon tumors, when compared to free anti-CTLA-4 [103]. This evidence concerns the gene CTLA4 and neoplasm.